Compounds > bim 23127
Page last updated: 2024-08-04 07:49:47

bim 23127

Description

BIM 23127: a neuromedin B receptor antagonist [MeSH]

Cross-References

ID SourceID
PubMed CID166639513
MeSH IDM0244974

Synonyms (1)

Synonym
bim 23127

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (26.67)18.2507
2000's7 (46.67)29.6817
2010's4 (26.67)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
quinacrine
1
acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor		2005200519.0low000100
verapamil
1
aromatic ether;
nitrile;
polyether;
tertiary amino compound		2007200717.0low000100
potassium chloride
1
inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer2005200519.0low000100
1,6-bis(cyclohexyloximinocarbonyl)hexane
1
carbamate ester;
organonitrogen compound		2005200519.0low000100
tiletamine hydrochloride
1
2005200519.0low000100
substance p
1
peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent		2004200420.0low000100
ng-nitroarginine methyl ester
1
alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor2007200717.0low000100
oseltamivir
1
acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic		201820186.0low000010
u 73122
1
aromatic ether;
aza-steroid;
maleimides		EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor2005200519.0low000100
u 73343
1
2005200519.0low000100
rc 3095
1
201620168.0low000010
arachidonic acid
1
icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite		2005200519.0low000100
u 0126
1
aryl sulfide;
dinitrile;
enamine;
substituted aniline		antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent		2013201311.0low000010
neurokinin b
5
polypeptide1994201818.4medium002120
neuromedin c
2
1994199828.0low002000
ac 7954
1
2-benzopyran2004200420.0medium000100
sb-710411
2
2004200519.5high000200
vasoactive intestinal peptide
1
2004200420.0low000100
neuromedin b
5
1994201818.4medium002120
gastrin-releasing peptide
2
2004200519.5low000200
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Anesthesia0
1
2007200717.0medium000100
Arachnoidal Cerebellar Sarcoma, Circumscribed0
2
201320169.5high000020
Benign Cerebellar Neoplasms0
1
2013201311.0medium000010
Cardiovascular Diseases0
1
2004200420.0medium000100
Medulloblastoma0
2
201320169.5high000020
Muscle Contraction0
2
1998200522.5high001100

Interactions (2)

ArticleYear
Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, , Volume: 32, Issue:1		2016
Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, , Volume: 29, Issue:12		2013